Chemoinformaics analysis of (1-HEXADECANOYLOXY-3-HYDROXYPROPAN-2-YL) (E)-OCTADEC-9-ENOATE
Molecular Weight | 594.962 | nRot | 33 |
Heavy Atom Molecular Weight | 524.402 | nRig | 47 |
Exact Molecular Weight | 594.522 | nRing | 0 |
Solubility: LogS | -4.149 | nHRing | 0 |
Solubility: LogP | 3.907 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 112 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 70 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 37 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 112.476 |
nHD | 1 | BPOL | 75.4325 |
QED | 0.216 |
Synth | 7.089 |
Natural Product Likeliness | 1.491 |
NR-PPAR-gamma | 0.102 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.994 |
Pgp-sub | 0.985 |
HIA | 0.929 |
CACO-2 | -5.521 |
MDCK | 0.0000153 |
BBB | 0.519 |
PPB | 0.886957 |
VDSS | 4.194 |
FU | 0.111615 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.982 |
CYP2c19-inh | 0.021 |
CYP2c19-sub | 0.931 |
CYP2c9-inh | 0.037 |
CYP2c9-sub | 0.122 |
CYP2d6-inh | 0.778 |
CYP2d6-sub | 0.873 |
CYP3a4-inh | 0.896 |
CYP3a4-sub | 0.931 |
CL | 3.472 |
T12 | 0.005 |
hERG | 0.948 |
Ames | 0.032 |
ROA | 0.998 |
SkinSen | 0.005 |
Carcinogencity | 0.284 |
EI | 0.004 |
Respiratory | 0.974 |
NR-Aromatase | 0.497 |
Antiviral | No |
Prediction | 0.617946 |